Rising global incidence of head and neck squamous cell carcinomas (HNSCC), expanding clinical association with human papillomavirus (HPV-16) infections, and rapid commercial adoption of non-invasive liquid biopsy assays are driving expansion across the global Head Neck Cancer Diagnostics Market. Head and neck cancer diagnostics encompass diagnostic imaging equipment (PET-CT, MRI), endoscopic...